@revivethera
Account based inCanada
About this account
- Account based in
- Canada
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
Revive Therapeutics (unofficial). Telling the story of Revive Therapeutics: Psychedelics, CBD, Covid-19 Oral Therapeutics - Bucillamine
Joined April 2021
- Tweets3.4K
- Following478
- Followers546
- Likes2.9K
These are not the @DRDC_RDDC results you are looking for but they are encouraging. #RVV #RVVTF
zenodo.org/records/21417964
Revive Therapeutics (unofficial) retweeted
A lot of research from Washington and Providence … 🤔 👇
Something coming guys …
Revive Therapeutics $RVV $RVVTF
@Revive_RVV
Revive Therapeutics (unofficial) retweeted
What also needs to be considered is that if Revive Therapeutics $RVV $RVVTF secures a government contract, it opens the door to all the other studies that are stalled due to lack of funding.
Therefore, Revive's potential for commercialization is greater than just a contract with the DRDC… We have long COVID, influenza, cancer, etc…
Revive Therapeutics (unofficial) retweeted
REVIVE THERAPEUTICS $RVV $RVVTF
DRDC is evaluating pharmacological compounds, including Bucillamine, that may mitigate nerve agent–induced brain injury.
MedicalCountermeasures(gov), explains its purpose, and explores how it supports preparedness, response, and protection of public health during emergencies.
$PF $JNJ $MRNA $VERU
youtube.com/watch?v=ueJ9QTsM…
Revive Therapeutics (unofficial) retweeted
REVIVE THERAPEUTICS ALERT
$RVV $RVVTF
“DRDC is evaluating compounds, including bucillamine, that may mitigate nerve agent-induced brain injury, and that positive outcomes could support further studies aimed at potential regulatory pathways in nerve agents or organophosphate pesticide poisoning”
$jnj $pf $mrna $veru
Revive Therapeutics (unofficial) retweeted
The Defense Playbook: Why Revive Therapeutics Could Be a High-Leverage Biotech Opportunity $RVV $RVVTF
@Revive_RVV $jnj $pf $mrna $veru
smallcappower.com/news/marke…
Revive Therapeutics (unofficial) retweeted
Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
bit.ly/4e91B0h
$RVV $RVVTF #Bucillamine #InfectiousDiseases #MedicalCountermeasures #RareDisorders #NerveAgent #DRDC #DefenceRDC #FDA #HealthCanada #monkeypox
Revive Therapeutics (unofficial) retweeted
Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity
bit.ly/4nm4Vu1
$RVV $RVVTF #Biotech #Research #HealthCare #Bucillamine #InfectiousDiseases #Pharmaceuticals #DrugDevelopment #DRDC #Braininjury
One thing to remember is that there aren't human trials for nerve agent exposure because it would be unethical. #Bucillamine 's safety record means it would go from positive results to @GovCanHealth Health Canada and @US_FDA approval in fairly quick succession.
Revive Therapeutics (unofficial) retweeted
Revive Therapeutics Strengthens Bucillamine IP Portfolio
Revive Therapeutics expands its #Bucillamine IP with new North American patent filings for nerve agent exposure and a granted Canadian patent for infectious diseases.
revivethera.com/2026/03/revi…
$RVV $RVVTF #Biotech #Research #HealthCare #Bucillamine #InfectiousDiseases #Pharmaceuticals #DrugDevelopment #ReviveTherapeutics #MedicalCountermeasures
Revive Therapeutics (unofficial) retweeted
ALERT VOLUME 🔝2M +
12X volume average 😍
Revive Therapeutics
(OTCQB: $RVVTF) (CSE: $RVV)
Intellectual property 👇
Market cap : $10 millions
$jnj $mrna $veru $tspt $pfe #biotech #Bucillamine #Covid #LongCovid #Mpox #psychedelic #weed @RobertKennedyJr @US_FDA
Revive Therapeutics (unofficial) retweeted
POSSIBLE BREAKOUT OUT 📈
Revive Therapeutics
(OTCQB: $RVVTF) (CSE: $RVV)
Revive is strategically positioning New Bucillamine to target public health emergencies such as pandemic influenza and emerging infectious diseases.
$jnj $mrna $veru $tspt $pfe #biotech #Bucillamine #Covid #LongCovid #Mpox #psychedelic #weed @RobertKennedyJr @US_FDA
